LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation.
about
Identifying the immunomodulatory components of helminthsGlycotope analysis in miracidia and primary sporocysts of Schistosoma mansoni: differential expression during the miracidium-to-sporocyst transformation.Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individualsTargeted glycoproteomic analysis reveals that kappa-5 is a major, uniquely glycosylated component of Schistosoma mansoni egg antigens.Deciphering the glycogenome of schistosomesSchistosoma japonicum egg specific protein SjE16.7 recruits neutrophils and induces inflammatory hepatic granuloma initiation.Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan MotifsProteomic Analysis of the Schistosoma mansoni MiracidiumComprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections.Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells.Glycoconjugates in host-helminth interactionsSchistosoma mansoni α1,3-fucosyltransferase-F generates the Lewis X antigenHelminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.Parasitic helminths: a pharmacopeia of anti-inflammatory molecules.Th2 responses in schistosomiasis.Lack of galectin-3 up-regulates IgA expression by peritoneal B1 lymphocytes during B cell differentiation.
P2860
Q26823533-92B56009-BE44-42C3-BD10-E416D1C9C3D6Q33471849-3B77996E-9574-463F-95C6-BAAF36C33FC5Q33684607-12C036E6-5157-4731-9DD5-6636477218C0Q33812839-AC693737-7952-4D19-BFBC-5223D0DA7C36Q33836598-22884E27-7AC5-4755-8944-F346307D33A5Q34007175-809BAA7C-36A4-4795-A852-949D2286ECBBQ35097824-46833C79-4308-413C-B0B7-E13A2C4D435AQ35604915-AA47D88D-9944-4287-9D3B-BF4E1EF96B0BQ35901075-A144BE1C-2781-4D21-93FD-B80125AECA5BQ35983706-2FDB62F0-B54D-441F-B38E-A8F9713B6919Q36313888-62F49323-0E6E-4E99-A25F-07844065E345Q37126736-EE5A32C9-7732-414D-ADDC-8C321A2882D4Q37223581-332B5ACD-0150-42C2-9BC7-5510D60F66A2Q37253393-3F7A112A-AAE4-4358-BDED-332BAC6BDDF7Q37349951-50ACFED4-332E-4DA1-B40C-8B3ED4A1E0A9Q38058759-AA953776-DAB1-4756-A97D-96271AC6ECAFQ41205968-0C42C6E7-ACEA-4A0E-8B73-B2BAD84865A9
P2860
LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@en
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@nl
type
label
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@en
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@nl
prefLabel
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@en
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@nl
P2093
P2860
P356
P1433
P1476
LacdiNAc- and LacNAc-containin ...... d hepatic granuloma formation.
@en
P2093
André M Deelder
Cornelis H Hokke
Eric A Van Marck
Koen K Van de Vijver
Werner Jacobs
P2860
P304
P356
10.1093/GLYCOB/CWJ058
P577
2005-11-10T00:00:00Z